Joy Wolfram leads a nanomedicine research lab with the goal of developing innovative nanoparticles that bring the next generation of treatments directly to the clinic. Joy Wolfram's resource list About TEDx TED
Tiede, Q. Chaudhry, Engineered nanomaterials in soils and water: how do they behave and could they pose a risk to human health? Nanomedicine 2 (2007) 919-927.Boxall, A. B., Tiede, K. & Chaudhry, Q. Engineered nanomaterials in soils and water: How do they behave and could they pose...
Nanomaterials particularly, Nanoparticles (NPs) are being used in various fields of medicine due to their exceptional characteristics [13]. The unprecedented breakthrough of NP-based therapeutics goes back to 1995, when the first nanomedicine named Doxil was approved by the FDA to treat ovarian cance...
nanoparticles nanocarrier nanomedicine atherosclerosis precision medicine Introduction Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, claiming millions of lives annually and posing a severe threat to human health.Citation1 Both the incidence and mortality of CVDs co...
Their core is usually hydrophobic if they aggregate in polar media, however, they do form inverted micellar system in non polar media with a hydrophilic core. Micelles are perfect carriers for drugs and have been used more than any other system of nanoparticles [30]. Micelles come first in ...
“In the field of nanomedicine, we want to minimize accumulation of nanoparticles in the body as much as possible. We don’t want them to get stuck in the kidneys, so it’s very important to understand how nanoparticles are eliminated from the proximal tubules,” Zheng said. “Also, if ...
Hazard and risk assessment of nanomaterials (NMs) face challenges due to, among others, the numerous existing nanoforms, discordant data and conflicting results found in the literature, and specific challenges in the application of strategies such as grouping and read-across, emphasizing the need for...
The FDA’s approval of the first RNAi-based drug was “proof these nanoparticles were not just tools we use in the lab to manipulate genes,” Anderson said in a new STAT Report on nanomedicine, “but proof they can be translated into approved medicines.” ...
Nanomedicine is the medical practice of using small, human-made particles to treat disease. These tiny particles work like building blocks or construction materials. Scientists can arrange them into different shapes, such as boxes or long tubes, to interact with tumor cells. In September 2020, res...
labeling antibodies, their fragments, and nanoparticles, that remain in circulation for hours to days to reach their targets. Additionally,89Zr doesn't require highly enriched targets, has lower production energy, and doesn't cause radioactive uptake in non-targeted organs compared with124I [40]....